Table 4. Characteristics of inpatients in univariable and multivariable models in a cross-sectional study of clinical predictors of coccidioidomycosis, Arizona, USA*.
| Characteristics | Univariable model |
Multivariable model |
|||
|---|---|---|---|---|---|
| OR (95% CI) | p value | aOR (95% CI) | p value | ||
| Demographics | |||||
| Age, y | 0.70 (0.50–0.98) | 0.035 | 0.72 (0.51–1.03) | 0.071 | |
| Non-White race |
2.42 (1.16–5.04) |
0.018
|
|
2.14 (0.51–1.03) |
0.061 |
| Symptoms | |||||
| Muscle aches | 0.45 (0.22–0.94) | 0.034 | 0.38 (0.17–0.84) | 0.017 | |
| Rash |
2.29 (1.08–4.84) |
0.030
|
|
2.20 (0.97–4.99) |
0.060 |
| Clinical feature | |||||
| Immunocompromised |
0.49 (0.25–0.94) |
0.033
|
|
0.64 (0.31–1.31) |
0.220 |
| Laboratory tests | |||||
| C-reactive protein, mg/L | 0.66 (0.46–0.94) | 0.023 | 0.72 (0.49–1.07) | 0.100 | |
| Eosinophil count, × 103/µL | 1.65 (1.17–2.34) | 0.005 | 1.50 (1.02–2.19) | 0.037 | |
| Total protein, g/dL | 1.50 (1.08–2.08) | 0.015 | 1.30 (0.91–1.87) | 0.152 | |
*Participants were recruited from among hospitalized patients, including 38 coccidioidomycosis-positive participants and 255 coccidioidomycosis-negative participants. Bold text indicates statistical significance. Bold text indicates statistical significance. aOR, adjusted odds ratio; OR, odds ratio.